Royal Bank of Canada
FCSC

Royal Bank of Canada’s Fibrocell Science Inc. FCSC Stock Holding History

Royal Bank of Canada’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed – – 7402
2019
Q1 		$0 Hold
1
– – ﹤0.01% 7300
2018
Q4 		$0 Hold
1
– – ﹤0.01% 7409
2018
Q3 		$0 Hold
1
– – ﹤0.01% 7135
2018
Q2 		$0 Hold
1
– – ﹤0.01% 6941
2018
Q1 		$0 Hold
1
– – ﹤0.01% 7070
2017
Q4 		$0 Hold
1
– – ﹤0.01% 7142
2017
Q3 		$0 Buy
+1
New +$16 ﹤0.01% 7163
2015
Q4 		– Sell
-71
Closed -$4K – 6958
2015
Q3 		$4K Sell
71
-27
-28% -$2.39K ﹤0.01% 6252
2015
Q2 		$8K Buy
+98
New +$6.59K ﹤0.01% 6148

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Royal Bank of Canada's FCSC Position: Q2 2019 in Review

Royal Bank of Canada sold out of Fibrocell Science Inc. (FCSC) in Q2 2019, closing a stake of 1 share.

Royal Bank of Canada first reported a position in FCSC in Q2 2015 and held it in 9 quarters. The position peaked at $8K in Q2 2015. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.

  • Royal Bank of Canada reported no remaining Fibrocell Science Inc. position as of Q2 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Fibrocell Science Inc. share in Q2 2019.
  • Royal Bank of Canada first reported a position in Fibrocell Science Inc. in Q2 2015 and held it in 9 quarters.
  • Royal Bank of Canada's Fibrocell Science Inc. position peaked at $8K in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2019.

Based on Royal Bank of Canada's 13F filing for Q2 2019, filed 14 Aug 2019.